How to buy Atea Pharmaceuticals shares

Atea Pharmaceuticals Inc (AVIR) is a publicly traded biotechnology business based in the US. It opened the day at $23.56 after a previous close of $23.58. During the day the price has varied from a low of $22.49 to a high of $24. The latest price was $23.4 (25 minute delay). Atea Pharmaceuticals is listed on the NASDAQ and employs 72 staff. All prices are listed in US Dollars.

Our top picks for where to buy Atea Pharmaceuticals shares:

Best for

0% commission

Best for

Beginner investments

Best for

Beginners

BEST FOR

US shares

Fees for buying 50x Atea Pharmaceuticals shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform	Customer feedback	Monthly fee	Min. initial deposit	Trading fee estimate
	★★★★★	£0	$50	£4.79 £963.73 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£5.66 £964.59 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£13.03 £971.96 total	Go to site Capital at risk
	Not yet rated	£0	No minimum	£4.79 £963.73 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£4.79 £963.73 total	Go to site Capital at risk
	★★★★★	£0	£1	£21.54 £980.47 total	Go to site Capital at risk

Full comparison of share dealing platforms

Alternative ways to invest in Atea Pharmaceuticals

• Invest in Atea Pharmaceuticals via a fund

  Buying shares in just one company can leave you more exposed to unexpected swings in the market than if you have a range of investments - a "diversified portfolio". Experts generally recommend having a broad mix of assets and funds that hold a ready-made portfolio of at least 50 different companies' shares, on the basis that drops in the value of some will be offset by rises elsewhere.

  Atea Pharmaceuticals is a major part of the NASDAQ index, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy Atea Pharmaceuticals stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

• See the technical analysis gauge

• See Atea Pharmaceuticals share price (NASDAQ:AVIR)

  Use our graph to track the performance of AVIR stocks over time.

  Share price volatility

  Over the last 12 months, Atea Pharmaceuticals's shares have ranged in value from as little as $2.94 up to $6.32. A popular way to gauge a stock's volatility is its "beta".

  Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atea Pharmaceuticals's is 0.176. This would suggest that Atea Pharmaceuticals's shares are less volatile than average (for this exchange).

  To put Atea Pharmaceuticals's beta into context you can compare it against those of similar companies.

  • Eiger Biopharmaceuticals (EIGR.US): 1.6331
  • Annexon Inc (ANNX.US): 0.5935
  • Chimerix (CMRX.US): 1.112
  • Otonomy (OTIC.US): 1.5717

• What's Atea Pharmaceuticals price performance over time?

  Historical closes compared with the last close of $23.4

  1 week (2023-09-21)	635.85%
  1 month (2023-09-01)	598.51%
  3 months (2023-06-30)	525.67%
  6 months (2023-03-31)	598.51%
  1 year (2022-09-30)	311.25%
  2 years (2021-10-01)	-44.30%

Invest in Atea Pharmaceuticals shares

Finder Award

• Start investing from $50
• Pay no stamp duty on UK shares
• Commission-free trading. Other fees may apply.

Go to site

Capital at risk

Frequently asked questions

• Does Atea Pharmaceuticals pay dividends?

  We're not expecting Atea Pharmaceuticals to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Atea Pharmaceuticals had its IPO on 30 October 2020). However, you can browse other dividend-paying shares in our guide.

  Currently 9.043% of Atea Pharmaceuticals shares are held by insiders and 74.215% by institutions.

• How many people work for Atea Pharmaceuticals?

  Latest data suggests 72 work at Atea Pharmaceuticals.

• When does the fiscal year end for Atea Pharmaceuticals?

  Atea Pharmaceuticals's fiscal year ends in December.

• Where is Atea Pharmaceuticals based?

  Atea Pharmaceuticals's address is: 125 Summer Street, Boston, MA, United States, 02110

• What is Atea Pharmaceuticals's ISIN number?

  Atea Pharmaceuticals's international securities identification number is: US04683R1068

• How to sell Atea Pharmaceuticals shares

  It's as easy to sell Atea Pharmaceuticals as it is to buy! Here's how to sell Atea Pharmaceuticals that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your Atea Pharmaceuticals shares. Your investment platform will let you know when your shares are sold

• Can you buy Atea Pharmaceuticals shares with a debit card?

  Most share dealing providers in the UK will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy Atea Pharmaceuticals shares?

  The easiest way to get hold of some Atea Pharmaceuticals shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Atea Pharmaceuticals shares.

• Do you need to complete a W8-BEN form if you want to invest in Atea Pharmaceuticals

  If you're investing in a US stock, you'll need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for Atea Pharmaceuticals?

  Financials

  Revenue TTM	$192.2 million
  Gross profit TTM	$-81,936,000
  Return on assets TTM	-12.79%
  Return on equity TTM	-16.81%
  Profit margin	0%
  Book value	$7.222
  Market capitalisation	$280.2 million

  TTM: trailing 12 months